Identifying influencing factors of metabolic syndrome in patients with major depressive disorder: A real-world study with Bayesian network modeling

被引:0
|
作者
Qi, Han [1 ,2 ,3 ]
Liu, Rui [1 ,2 ,3 ]
Dong, Cheng-Cheng [1 ,2 ,3 ]
Zhu, Xue-Quan [1 ,2 ,3 ]
Feng, Yuan [1 ,2 ,3 ]
Wang, Hai-Ning [4 ]
Li, Lei [5 ,7 ,8 ,9 ]
Chen, Fei [6 ]
Wang, Gang [1 ,2 ,3 ]
Yan, Fang [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Anding Hosp, Natl Clin Res Ctr Mental Disorders, Beijing Key Lab Mental Disorders, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Anding Hosp, Natl Ctr Mental Disorders, Beijing, Peoples R China
[3] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing 100088, Peoples R China
[4] Peking Univ Third Hosp, Dept Endocrinol & Metab Dis, Beijing, Peoples R China
[5] Peking Univ Third Hosp, Dept Cardiol, Beijing, Peoples R China
[6] Peking Univ, Peking Univ Hlth Sci Ctr, Grad Sch, Beijing, Peoples R China
[7] Peking Univ, State Key Lab Vasc Homeostasis & Remodeling, Beijing, Peoples R China
[8] Peking Univ, NHC Key Lab Cardiovasc Mol Biol & Regulatory Pepti, Beijing, Peoples R China
[9] Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China
关键词
Major depressive disorder; Metabolic syndrome; Bayesian network; Real-world data; Influencing factors; MENTAL-DISORDERS; PREVALENCE; ASSOCIATION; HEALTH; RISK;
D O I
10.1016/j.jad.2024.07.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The bidirectional relationships between metabolic syndrome (MetS) and major depressive disorder (MDD) were discovered, but the influencing factors of the comorbidity were barely investigated. We aimed to fully explore the factors and their associations with MetS in MDD patients. Methods: The data were retrieved from the electronic medical records of a tertiary psychiatric hospital in Beijing from 2016 to 2021. The influencing factors were firstly explored by univariate analysis and multivariate logistic regressions. The propensity score matching was used to reduce the selection bias of participants. Then, the Bayesian networks (BNs) with hill-climbing algorithm and maximum likelihood estimation were preformed to explore the relationships between influencing factors with MetS in MDD patients. Results: Totally, 4126 eligible subjects were included in the data analysis. The proportion rate of MetS was 32.6 % (95 % CI: 31.2 %-34.1 %). The multivariate logistic regression suggested that recurrent depression, uric acid, duration of depression, marriage, education, number of hospitalizations were significantly associated with MetS. In the BNs, number of hospitalizations and uric acid were directly connected with MetS. Recurrent depression and family history psychiatric diseases were indirectly connected with MetS. The conditional probability of MetS in MDD patients with family history of psychiatric diseases, recurrent depression and two or more times of hospitalizations was 37.6 %. Conclusion: Using the BNs, we found that number of hospitalizations, recurrent depression and family history of psychiatric diseases contributed to the probability of MetS, which could help to make health strategies for specific MDD patients.
引用
收藏
页码:308 / 316
页数:9
相关论文
共 50 条
  • [1] Factors related to the length of stay for major depressive disorder patients in China: A real-world retrospective study
    Cheng, Peng
    Wang, Lirong
    Xu, Lizhi
    Zhou, Ying
    Zhao, Guangju
    Zhang, Li
    Li, Weihui
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [2] Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: Population-based study Metabolic syndrome in current depressive episode
    Moreira, Fernanda Pedrotti
    Jansen, Karen
    Cardoso, Taiane de Azevedo
    Mondin, Thaise Campos
    da Silva Magalhaes, Pedro Vieira
    Kapczinski, Flavio
    de Mattos Souza, Luciano Dias
    da Silva, Ricardo Azevedo
    Oses, Jean Pierre
    Wiener, Carolina David
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 92 : 119 - 123
  • [3] Gender differences in clinical characteristics and influencing factors of suicide attempts in first-episode and drug-naïve major depressive disorder patients with comorbid metabolic syndrome
    Sun, Ping
    Huang, Yingying
    Yu, Hui
    Wu, Xiaohui
    Chen, Jun
    Fang, Yiru
    Zhang, Xiangyang
    BMC PSYCHIATRY, 2024, 24 (01)
  • [4] Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
    Touya, Maelys
    Lawrence, Debra F.
    Kangethe, Anne
    Chrones, Lambros
    Evangelatos, Themmi
    Polson, Michael
    BMC PSYCHIATRY, 2022, 22 (01)
  • [5] Metabolic syndrome in patients with bipolar disorder: Comparison with major depressive disorder and non-psychiatric controls
    Silarova, Barbora
    Giltay, Erik J.
    Dortland, Arianne Van Reedt
    Van Rossum, Elisabeth F. C.
    Hoencamp, Erik
    Penninx, Brenda W. J. H.
    Spijker, Annet T.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 78 (04) : 391 - 398
  • [6] PREVALENCE OF METABOLIC SYNDROME AND ITS ASSOCIATED FACTORS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Charnsil, Chawanun
    Pilakanta, Sudrak
    Panikul, Suksiri
    ASEAN JOURNAL OF PSYCHIATRY, 2015, 16 (02): : 176 - 180
  • [7] Chronic medical conditions and metabolic syndrome as risk factors for incidence of major depressive disorder: A longitudinal study based on 4.7 million adults in South Korea
    Han, Kyu-Man
    Kim, Mm Sun
    Kim, Aram
    Paik, Jong-Woo
    Lee, Juneyoung
    Ham, Byung-Joo
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 257 : 486 - 494
  • [8] Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
    Maëlys Touya
    Debra F. Lawrence
    Anne Kangethe
    Lambros Chrones
    Themmi Evangelatos
    Michael Polson
    BMC Psychiatry, 22
  • [9] Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study
    Di Nicola, M.
    Adair, M.
    Rieckmann, A.
    Christensen, M. Cronquist
    JOURNAL OF PSYCHOPHARMACOLOGY, 2024, 38 (07) : 615 - 623
  • [10] Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
    Mattingly, Gregory W.
    Ren, Hongye
    Christensen, Michael Cronquist
    Katzman, Martin A.
    Polosan, Mircea
    Simonsen, Kenneth
    Hammer-Helmich, Lene
    FRONTIERS IN PSYCHIATRY, 2022, 13